Clinical Trial Update: TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TALAVE evaluating induction talazoparib followed by combination of talazoparib and avelumab in advanced breast cancer (Phase 1/Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avelumab (avelumab)
• Talazoparib (talazoparib)

Snippet

Sponsor: Georgetown University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING